SEARCH RESULTS

Curve Therapeutics raise £40.5m Series A investment through Pfizer Ventures

News | Emma Blunt | Tue, 02/04/2024 | 10:32

The University of Southampton spin-out and pharmaceutical company will use the recent investment to begin clinical trials of its Microcycle platform.   Curve Therapeutics is working to develop new drugs for difficult-to-address cancer targets with its novel screening platform, Microcycle. The gene-encoded platform enables cyclic peptides – an amino acid...

• View

HubSpot

Content Page | recognition | Mon, 01/04/2024 | 23:59

HubSpot HubSpot is an all in one CRM and your ticket to a single source of truth for your sales, marketing and customer service.

• View

Ventures Showcase Investment Opportunity at GCV 2024 – Expression of Interest Received

Content Page | Emma Blunt | Thu, 28/03/2024 | 17:40

Ventures Showcase Investment Opportunity at Global Corporate Venturing Symposium, 25-26 June 2024

• View

GCV VENTURE SHOWCASE INVESTMENT OPPORTUNITY – Ventures Application

Programme | Emma Blunt | Wed, 27/03/2024 | 16:18

• View

Applicant Criteria – Venture Showcase Investment Opportunity at GCV 2024

Content Page | Emma Blunt | Mon, 25/03/2024 | 14:02

• View

Finchetto awarded £1m grant in SBRI Future Telecoms Challenge

News | Emma Blunt | Fri, 22/03/2024 | 13:01

UKTIN member company, Finchetto, has been awarded £1m to develop the world’s first fully optical switch for telecoms networks. The £70m Technology Missions Fund (TMF) Future Telecoms Mission, delivered by UK Research and Innovation (UKRI), has provided the funding to advance technologies vital for upcoming telecom networks like 6G. Finchetto...

• View